CPMV Mosaic Immunoengineering, Inc.
Fundamentals / CIK 0000836564 / USDMosaic Immunoengineering, Inc. reported $151 in total assets and a net loss of $688K through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CPMV in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$602K Operating profit
-
Net Income FY 2025-$688K GAAP bottom line
-
Diluted EPS FY 2025-$0.10 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$151 Total debt: --
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | May 31 | May 31 | May 31 | May 31 | May 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research & Development | $64K | $184K | $435K | $1.05M | $1.46M | -- | -- | -- | -- | -- |
| Selling, General & Admin | -- | -- | -- | -- | -- | $996K | $734K | $1.05M | $1.22M | $1.58M |
| Total Operating Expenses | $616K | $880K | $1.40M | $2.63M | $3.50M | $996K | $734K | $1.05M | $1.22M | $1.58M |
| Operating Income | -$616K | -$880K | -$1.40M | -$2.63M | -$3.50M | -$996K | -$734K | -$1.05M | -$1.22M | -- |
| EBITDA | -- | -- | -- | -- | -- | -$996K | -$734K | -$1.05M | -$1.22M | -- |
| Interest Expense | $10K | $7.0K | $0 | -- | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$685K | -$920K | -$1.01M | -$2.38M | -$3.68M | -$1.06M | -$797K | -$1.26M | -$43K | -$1.26M |
| Income Tax Expense | $2.4K | $2.4K | $2.4K | $2.4K | $2.4K | $1.6K | $1.6K | -$50K | $2.4K | $2.4K |
| Net Income | -$688K | -$922K | -$1.01M | -$2.38M | -$3.68M | -$1.06M | -$798K | -$1.21M | -$45K | -$1.27M |
| Basic EPS | -$0.10 | -$0.13 | -$0.14 | -$0.33 | -$0.55 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted EPS | -$0.10 | -$0.13 | -$0.14 | -$0.33 | -$0.55 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | 7.2M | 7.2M | 7.2M | 7.2M | 6.7M | 398.5M | 398.5M | 398.5M | 398.5M | 398.5M |
| Diluted Shares Outstanding | -- | 7.2M | 7.2M | 7.2M | 6.7M | 398.5M | 398.5M | 398.5M | 398.5M | 398.5M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $16K | $16K | $16K | $16K | $16K | $16K | $16K | $16K |
| Total Operating Expenses | $142K | $157K | $155K | $148K | $144K | $149K | $175K | $150K |
| Operating Income | -$142K | -$157K | -$155K | -$148K | -$144K | -$149K | -$175K | -$150K |
| Interest Expense | $2.5K | $2.5K | $2.5K | $2.5K | $2.5K | $2.5K | $2.5K | $3.0K |
| Income Before Tax | -$163K | -$177K | -$175K | -$169K | -$165K | -$170K | -$181K | -$151K |
| Income Tax Expense | $2.4K | $0 | $0 | $0 | $0 | $2.4K | $0 | $2.4K |
| Net Income | -$166K | -$177K | -$175K | -$169K | -$165K | -$172K | -$181K | -$153K |
| Basic EPS | -$0.02 | -$0.02 | -$0.02 | -- | -$0.02 | -$0.02 | -$0.03 | -- |
| Diluted EPS | -$0.02 | -$0.02 | -$0.02 | -- | -$0.02 | -$0.02 | -$0.03 | -- |
| Basic Shares Outstanding | 7.2M | 7.2M | 7.2M | -- | 7.2M | 7.2M | 7.2M | -- |
| Diluted Shares Outstanding | 7.2M | 7.2M | 7.2M | -- | 7.2M | 7.2M | 7.2M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | May 31 | May 31 | May 31 | May 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $3.6K | $115K | $156K | $221K | $226K | $353K | $500 | $787K | $2.30M | $980K |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | $0 | $750K | $0 | $2.20M |
| Cash & Short-Term Investments | $3.6K | $115K | $156K | $221K | $226K | $353K | $500 | $1.54M | $2.30M | $3.18M |
| Total Current Assets | $20K | $142K | $180K | $261K | $269K | $458K | $563 | $1.79M | $2.33M | $3.32M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | $326 | $814 | $1.3K | $1.9K |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Total Non-Current Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $135K | $253K | $444K |
| Total Assets | $20K | $142K | $180K | $261K | $269K | $458K | $563 | $1.92M | $2.58M | $3.76M |
| Accounts Payable | $133K | $135K | $118K | $133K | $114K | $86K | $0 | $8.9K | $45K | $14K |
| Total Current Liabilities | $6.03M | $5.54M | $4.73M | $3.92M | $2.33M | $880K | $1.0K | $228K | $85K | $57K |
| Total Non-Current Liabilities | $1.47M | $1.39M | $1.32M | $1.23M | $735K | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $7.50M | $6.93M | $6.05M | $5.15M | $3.07M | $880K | $1.0K | $228K | $85K | $57K |
| Common Stock | $72 | $72 | $72 | $72 | $72 | $8 | $0 | $4.4K | $4.4K | $4.4K |
| Retained Earnings | -$9.53M | -$8.84M | -$7.92M | -$6.91M | -$4.53M | -$843K | -$511 | -$61.13M | -$60.33M | -$59.12M |
| Total Stockholders' Equity | -$7.48M | -$6.79M | -$5.87M | -$4.88M | -$2.80M | -$423K | -$448 | $1.70M | $2.50M | $3.70M |
| Total Equity | -$7.48M | -$6.79M | -$5.87M | -$4.88M | -$2.80M | -$423K | -$448 | $1.70M | $2.50M | $3.70M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $151 | $26 | $72 | $3.6K | $32K | $54K | $86K | $115K |
| Cash & Short-Term Investments | $151 | $26 | $72 | $3.6K | $32K | $54K | $86K | $115K |
| Total Current Assets | $151 | $3.3K | $9.8K | $20K | $55K | $58K | $98K | $142K |
| Total Non-Current Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $151 | $3.3K | $9.8K | $20K | $55K | $58K | $98K | $142K |
| Accounts Payable | $197K | $183K | $167K | $133K | $134K | $134K | $138K | $135K |
| Total Current Liabilities | $6.47M | $6.33M | $6.18M | $6.03M | $5.91M | $5.77M | $5.66M | $5.54M |
| Total Non-Current Liabilities | $1.52M | $1.50M | $1.48M | $1.47M | $1.45M | $1.43M | $1.41M | $1.39M |
| Total Liabilities | $7.99M | $7.83M | $7.66M | $7.50M | $7.36M | $7.20M | $7.07M | $6.93M |
| Common Stock | $72 | $72 | $72 | $72 | $72 | $72 | $72 | $72 |
| Retained Earnings | -$10.04M | -$9.88M | -$9.70M | -$9.53M | -$9.36M | -$9.19M | -$9.02M | -$8.84M |
| Total Stockholders' Equity | -$7.99M | -$7.83M | -$7.65M | -$7.48M | -$7.31M | -$7.14M | -$6.97M | -$6.79M |
| Total Equity | -$7.99M | -$7.83M | -$7.65M | -$7.48M | -$7.31M | -$7.14M | -$6.97M | -$6.79M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | May 31 | May 31 | May 31 | May 31 | May 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$688K | -$922K | -$1.01M | -$2.38M | -$3.68M | -$1.06M | -$798K | -$1.21M | -$45K | -$1.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | $488 | $489 | $763 | $826 | $1.3K |
| Stock-Based Compensation | $0 | $4.9K | $22K | $295K | $1.31M | -- | -- | -- | -- | $0 |
| Operating Cash Flow | -$111K | -$241K | -$497K | -$690K | -$679K | -$987K | -$761K | -$880K | -$1.31M | -$1.58M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | $0 | -$1.5K | -$2.7K | $0 |
| Free Cash Flow | -- | -- | -- | -- | -- | -- | -$761K | -$882K | -$1.31M | -$1.58M |
| Purchases of Investments | -- | -- | -- | -- | -- | -$250K | -$750K | -$2.70M | -$2.95M | -$2.45M |
| Investing Cash Flow | -- | $0 | $433K | $343K | $28K | $750K | -$573K | $2.20M | $1.13M | $58K |
| Common Stock Issued | -- | -- | -- | -- | $0 | -- | -- | -- | -- | -- |
| Financing Cash Flow | $0 | $200K | $0 | $342K | $525K | -- | -- | -- | -- | -- |
| Net Change in Cash | -$111K | -$41K | -$64K | -$5.5K | -$127K | -$237K | -$1.33M | $1.32M | -$180K | -$1.52M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$166K | -$177K | -$175K | -$169K | -$165K | -$172K | -$181K | -$153K |
| Stock-Based Compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Cash Flow | $125 | -$46 | -$3.5K | -$28K | -$22K | -$32K | -$29K | -$21K |
| Investing Cash Flow | -- | -- | -- | -- | -- | -- | -- | $0 |
| Net Change in Cash | $125 | -$46 | -$3.5K | -$28K | -$22K | -$32K | -$29K | $109K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | May 31 | May 31 | May 31 | May 31 | May 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -47.1% | -48.5% | -1.2% | -33.8% |
| Return on Assets (ROA) | -3459.6% | -651.1% | -561.6% | -911.2% | -1367.2% | -188370.9% | -41.5% | -46.9% | -1.2% | -33.1% |
| Current Ratio | 0.00x | 0.03x | 0.04x | 0.07x | 0.12x | 0.56x | 7.84x | 27.43x | 58.62x | 42.89x |
| Quick Ratio | 0.00x | 0.02x | 0.03x | 0.06x | 0.10x | 0.49x | 6.74x | 27.09x | 56.25x | 42.37x |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -- | -- | -- | -211.4% | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Assets (ROA) | -455548.3% | -20968.4% | -6938.1% | -3459.6% | -1214.8% | -1201.3% | -833.3% | -651.1% |
| Current Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.02x | 0.03x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.02x | 0.02x |